the German Kogenate Study Group. A multicenter pharmacosurveillance study for the evaluation of the efficacy and safety of recombinant factor VIII in the treatment of patients with haemophilia A - Aygören-Pürsün, E; Scharrer, I (Thromb Haemost, 1997)